Company intelligence / Profile preview
Nuovo Biologics
Davie, Florida, United States
- Ownership
- Private
- Employees
- ~3
- Development stage
- Other
01
Overview
Nuovo Biologics was focused on developing therapeutic protein drugs with antiviral and oncology applications. The company's lead program PVX demonstrated broad-spectrum antiviral activity in vitro and pilot studies in companion animals against herpes, influenza, and retroviruses. A second program MMX targets malignant tumors.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Peptides
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Nuovo Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nuovo Biologics.